Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation - PubMed (original) (raw)
. 1996 Oct-Dec;29(2-3):253-61.
doi: 10.1007/BF02815006.
Affiliations
- PMID: 8971700
- DOI: 10.1007/BF02815006
Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation
L Baum et al. Mol Chem Neuropathol. 1996 Oct-Dec.
Abstract
Highly phosphorylated tau protein is the main component of paired helical filaments (PHF), which comprise the neurofibrillary tangles (NFT) in some neurons of patients with Alzheimer disease (AD). Glycogen synthase kinase 3 (GSK3) phosphorylates tau in vitro at several sites also found to be phosphorylated in PHF-tau; tau is phosphorylated at these sites in both AD and normal control (NC) brains, although the extent of phosphorylation is far greater in tau from AD. If GSK3 levels are increased in AD, then tau phosphorylation and perhaps PHF formation may occur. To quantify GSK3, blots of AD and NC brain supernatant and particulate fractions were probed with antibodies to GSK3. In particulate fractions of AD compared to NC, GSK3 alpha immunoreactivity did not increase, but in fact, decreased 40%, and GSK3 beta immunoreactivity decreased 30%. GSK3 alpha and GSK3 beta levels correlated well with each other. GSK3 levels correlated negatively with numbers of NFT.
Similar articles
- Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
Imahori K, Uchida T. Imahori K, et al. J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review. - Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement.
Baum L, Seger R, Woodgett JR, Kawabata S, Maruyama K, Koyama M, Silver J, Saitoh T. Baum L, et al. Brain Res Mol Brain Res. 1995 Dec 1;34(1):1-17. doi: 10.1016/0169-328x(95)00111-5. Brain Res Mol Brain Res. 1995. PMID: 8750856 - The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP. Leroy K, et al. Acta Neuropathol. 2002 Feb;103(2):91-9. doi: 10.1007/s004010100435. Epub 2001 Nov 29. Acta Neuropathol. 2002. PMID: 11810173 - Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S, et al. Lovestone S, et al. Curr Biol. 1994 Dec 1;4(12):1077-86. doi: 10.1016/s0960-9822(00)00246-3. Curr Biol. 1994. PMID: 7704571 - GSK3 and tau: two convergence points in Alzheimer's disease.
Hernandez F, Lucas JJ, Avila J. Hernandez F, et al. J Alzheimers Dis. 2013;33 Suppl 1:S141-4. doi: 10.3233/JAD-2012-129025. J Alzheimers Dis. 2013. PMID: 22710914 Review.
Cited by
- Overexpression of GSK3betaS9A resulted in tau hyperphosphorylation and morphology reminiscent of pretangle-like neurons in the brain of PDGSK3beta transgenic mice.
Li B, Ryder J, Su Y, Moore SA Jr, Liu F, Solenberg P, Brune K, Fox N, Ni B, Liu R, Zhou Y. Li B, et al. Transgenic Res. 2004 Aug;13(4):385-96. doi: 10.1023/b:trag.0000040039.44899.6f. Transgenic Res. 2004. PMID: 15517997 - Molecular differences in Alzheimer's disease between male and female patients determined by integrative network analysis.
Sun LL, Yang SL, Sun H, Li WD, Duan SR. Sun LL, et al. J Cell Mol Med. 2019 Jan;23(1):47-58. doi: 10.1111/jcmm.13852. Epub 2018 Nov 5. J Cell Mol Med. 2019. PMID: 30394676 Free PMC article. - Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias.
Xing H, Lim YA, Chong JR, Lee JH, Aarsland D, Ballard CG, Francis PT, Chen CP, Lai MK. Xing H, et al. Mol Brain. 2016 Sep 8;9(1):84. doi: 10.1186/s13041-016-0264-9. Mol Brain. 2016. PMID: 27609071 Free PMC article. - Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.
Nübling G, Bader B, Levin J, Hildebrandt J, Kretzschmar H, Giese A. Nübling G, et al. Mol Neurodegener. 2012 Jul 23;7:35. doi: 10.1186/1750-1326-7-35. Mol Neurodegener. 2012. PMID: 22824345 Free PMC article. - Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility.
Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST. Morfini G, et al. EMBO J. 2002 Feb 1;21(3):281-93. doi: 10.1093/emboj/21.3.281. EMBO J. 2002. PMID: 11823421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical